http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102836145-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
filingDate 2012-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15220218b5d3dd5b635f011380ce0ae1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb332410376520edc39232677bb8c58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5ea0c512bbb0239ec4b65a7028d1827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c526ad37ab564df9a0363d123ec24d9
publicationDate 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102836145-B
titleOfInvention Applications of pterostilbene in preparation of medicines for preventing and treating chronic glomerular disease
abstract The invention relates to new medical applications of a natural monomer compound pterostilbene, in particular to applications of the pterostilbene in preparation of medicines for preventing and treating a chronic glomerular disease, and applications of pterostilbene in preparation of medicines for preventing and treating progressive chronic glomerular disease. Animal test results show that the pterostilbene has an obvious effect on prevention and improvement of a glomerular function and an organic injury of a fructose model rat renal. The pterostilbene is matched up with relevant adjuvants, a conventional preparation method can be utilized to obtain a health care product or a medicine aiming at preventing and treating the glomerular disease. The above health care product and the medicine can be used for the diseases relevant to the chronic glomerular lesion, such as diabetes and metabolic syndrome and the like, so that the glomerular progressive course in the relevant diseases can be delayed and improved.
priorityDate 2012-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227373
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1071187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451822344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5984
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID69266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID69266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407699550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565814
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1071187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7058172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607

Total number of triples: 31.